A few weeks ago we wrote that the Centers for Medicare and Medicaid had proposed a system in which they would only cover Aduhelm for patients enrolled in a clinical trial. This would exclude people without access to a trial, and trial enrollment could be limited. The proposed decision requires a 30 day public comment period ... and boy, are there comments. A record number of comments. Not surprisingly, there are comments for the draft and comments against it.
So who's for and who's against? In this politicized age, people wonder about red states and blue states. Apparently, red states tend to oppose the proposed decision, as 78 Republican congressmen have signed a letter demanding greater access to the treatment. But 4,600 comments favoring the decision came from a political organization aligned with Bernie Sanders.
It's been noted that the comments result from organized campaigns, since the language in many letters are very similar to the language in others.
The comment period ended February 10, and a decision is expected in April. If you're curious, you can read more here.
No comments:
Post a Comment